Document is current
Any future updates will be listed below
-
Authors
Judson, Ian https://orcid.org/0000-0002-4766-5304
Jones, Robin L. https://orcid.org/0000-0003-4173-3844
Wong, Newton A. C. S.
Dileo, Palma
Bulusu, Ramesh
Smith, Myles
Almond, Max
- License Information
-
More Information
Article History
Received: 9 January 2024
Revised: 21 March 2024
Accepted: 25 March 2024
First Online: 5 June 2024
Competing interests
: The following authors reported no competing interests: IJ, MA, NW. The following received honoraria from Deciphera for attendance at advisory boards etc: MS, PD, RB and RJ. RB also received honoraria from Blueprint. RJ also reports receipt of grants from MSD and GSK and consultation fees from Adaptimmune, Astex, Athenex, Bayer, Boehringer Ingelheim, Blueprint, Clinigen, Eisai, Epizyme, Daichii, Immunedesign, Immunicum, Karma Oncology, Lilly, Merck, Mundipharma, Pharmamar, Springworks, SynOx, Tracon, UptoDate.
